Cover Image
Market Research Report

Pharmaceutical Packaging to 2021

Published by Allied Development Corp. Product code 235030
Published Content info 400 Pages
Delivery time: 1-2 business days
Price
Back to Top
Pharmaceutical Packaging to 2021
Published: November 21, 2016 Content info: 400 Pages
Description

"Pharmaceutical Packaging to 2021" examines the global pharmaceutical packaging industry, which will reach US$10.6 billion in primary packaging value in 2016. This comprehensive study examines industry technology, industry participants, and market trends in order to forecast the market through 2021.

This large packaging market will continue to grow due to:

  • the growing market of aged consumers
  • government regulations driving huge programs such as serialization
  • innovative packages for child resistance
  • new technology for packages that ensure patients adhere to their drug regimens
  • increasing demands from more sophisticated pharmaceuticals
  • increasing demands from new drug delivery systems

Quantitative forecasts include primary packaging, secondary packaging, by geographic region, child-resistance, patient compliance, and many others.

Table of Contents
Product Code: RPP16A

Table of Contents

Section I: Introduction

  • A. Pharmaceuticals defined
  • B. Pharmaceutical packaging defined
  • C. Study organization
  • D. Methodology
  • E. Geographic regions
  • F. Conventions

Section II: Technology

  • A. Technology priorities
    • 1. Drug safety and efficacy
    • 2. Drug sensitivity
    • 3. Drug delivery method
    • 4. Regulations drug safety and efficacy
    • 5. Packaging cost
    • 6. Environment and health
    • 7. Packaging requirements
  • B. Devices versus packages definition
    • 1. Inhalers
    • 2. Pen injection systems
    • 3. Auto-injectors
    • 4. Wearable devices
  • C. Primary packaging
    • 1. Ampules
    • 2. Blister packs
    • 3. Bottles
    • 4. Canisters
    • 5. Cartridges
    • 6. Intravenous (IV) bags
    • 7. Mini-jars
    • 8. Pouches
    • 9. Pre-fillable syringes
    • 10. Tubes
    • 11. Vials
    • 12. Other primary containers
    • 13. Closures
    • 14. Innerseals
  • D. Secondary packaging
    • 1. Blister cards and wallets
    • 2. Folding cartons
    • 3. Trays
    • 4. Other
    • 5. Labels
    • 6. Shrink bands
  • E. Child-resistant packaging
    • 1. Multi-dose packaging
    • 2. Unit-dose packaging
    • 3. Additional child-resistant technologies
  • F. Compliance packaging
    • 1. Calender blister pack
    • 2. Dose indicators
    • 3. Electronic compliance monitoring (ECM)
    • 4. ECM closure
    • 5. ECM blister pack
    • 6. Wallet
    • 7. Summary
  • G. Tamper-evident packaging
    • 1. Inherently tamper-evident packages
    • 2. Not inherently tamper evident
    • 3. Pre-filled syringes
  • H. Unit-dose packaging
  • I. Anti-counterfeit packaging
    • 1. Existing solutions
    • 2. Serialization
  • J. Labeling
  • K. Identification and tracking
    • 1. Barcodes
    • 2. Radio frequency identification (RFID)
    • 3. Near field communications
  • L. Active packaging
  • M. Packaging processes for sterile drugs
    • 1. Traditional aseptic packaging
    • 2. Aseptic packaging with barrier isolation technology
    • 3. Terminal sterilization (in-package sterilization)
  • N. Packaging processes for non-sterile drugs
  • O. Pharmaceutical packaging materials
    • 1. Polymers
    • 2. Glass
    • 3. Aluminum foil
    • 4. Paper
    • 5. Paperboard
    • 6. Other
  • P. Pharmaceutical packaging structures
    • 1. Blister pack structures
    • 2. Bottles, vials, ampules, cartridges, and mini-jars
    • 3. Pouch structures
    • 4. Pre-filled syringes
    • 5. IV bags
    • 6. Tube structures
    • 7. Secondary packaging
    • 8. Other structures
  • Q. Pharmaceutical packaging equipment technology
    • 1. Filling equipment
    • 2. Filling equipment suppliers

Section III: Market Trends and Projections

  • A. Pharmaceutical industry drivers and trends
    • 1. Government policies
    • 2. Macro environment
    • 3. New drugs
    • 4. New drug delivery techniques
    • 5. Biologics
    • 6. Generic drugs
    • 7. Delivery devices
    • 8. New drug production techniques
  • B. Pharmaceutical packaging industry drivers and trends
    • 1. Underlying product trends
    • 2. Regulatory environment
    • 3. Government healthcare programs
    • 4. Product differentiation
    • 5. Drug safety
    • 6. Conversions from prescription to OTC
    • 7. Alternative drug delivery methods
    • 8. Environmental
    • 9. Drug protection requirements
  • C. Global primary packaging volume by delivery method
    • 1. Cutaneous
    • 2. Inhaled
    • 3. Nasal
    • 4. Ocular
    • 5. Oral delivery
    • 6. Parenteral
    • 7. Transdermal
    • 8. Other
  • D. Global primary packaging volume by package type
    • 1. Ampules
    • 2. Blister packs
    • 3. Bottles
    • 4. Canisters
    • 5. Cartridges
    • 6. IV bags
    • 7. Mini-jars
    • 8. Pouches
    • 9. Pre-fillable syringes
    • 10. Tubes
    • 11. Vials
    • 12. Other
    • 13. Closures
    • 14. Innerseals
  • E. Global primary packaging value segmented by package type
  • F. Asia primary packaging volume by packaging type
  • G. China primary packaging volume by packaging type
  • H. Europe primary packaging volume by packaging type
  • I. Japan primary packaging volume by packaging type
  • J. North America primary packaging volume by package type
  • K. ROW primary packaging volume by packaging type
  • L. Global primary packaging volume by geographic region
    • 1. Asia
    • 2. China
    • 3. Europe
    • 4. Japan
    • 5. North America
    • 6. Rest of World (ROW)
  • M. Global primary packaging value by geographic region
  • N. Global secondary packaging volume by package type
    • 1. Blister cards and wallets
    • 2. Folding cartons
    • 3. Trays
    • 4. Other
    • 5. Labels
    • 6. Shrink bands
  • O. Global secondary packaging value by package type
  • P. Primary packaging volume segmented by regulatory status
    • 1. Over-the-counter pharmaceuticals
    • 2. Prescription
    • 3. Projection
  • Q. Primary packaging volume by drug production process
    • 1. Chemical
    • 2. Biological
    • 3. Projection
  • R. Primary packaging volume by distribution channel
    • 1. Institutional
    • 2. Retail
    • 3. Projection
  • S. Primary packaging volume segmented by compliance features
    • 1. Compliance
    • 2. Projection
  • T. Primary packaging volume segmented by anti-counterfeiting
    • 1. Anti-counterfeit
    • 2. Projection
  • U. Primary packaging volume by child resistance
    • 1. Child resistance
    • 2. Projection
  • V. Primary packaging volume by tamper evidence
    • 1. Tamper evidence
    • 2. Projection
  • W. Primary packaging volume segmented by material type
    • 1. Primary packaging
    • 2. Blister pack
    • 3. Tubes
    • 4. Pouches and strip packs
    • 5. Secondary packaging

Section IV: Packaging Producers

Section V: Equipment Suppliers

Section VI: Glossary

Back to Top